Acute Porphyria Drug Database

Monograph

S01AE03 - Ciprofloxacin
Propably not porphyrinogenic
PNP

Rationale
Conflicting references regarding porphyrinogenicity, but the systemic load probably is insignificant, being about 1/500 of the peroral dose of 250 mg.
Chemical description
Quinolone chemotherapeutic in eye drops 3mg/mL, used in treatment of corneal vulnera and conjunctivitis (2 drops every 15 minutes during the first 6 hours, after that 2 drops every 30 minutes the rest of the day, etc. Continued for two weeks.) Absorbed, but the plasma concentration is low, varying between 0 and 4,7 µg/mL. South African list: use with extreme caution only French list: authorized
IPNet drug reports
Uneventful use reported in 1 patient with acute porphyria.
Similar drugs
Explore alternative drugs in similar therapeutic classes S01A / S01AE or go back.
Tradenames
This list comprises raw data collected from different countries. In some cases, a more comprehensive list of available drug packages is included. Consequently, very similar terms may therefore appear multiple times. Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.


Cetraflux · Oftacilox Ciloxan · Ciprofloxacin Ciloxan Cilox · Ciloxan Cipronex Ciloxan Ciloxan Marocen
 
© NAPOS 2025
An unhandled error has occurred. Reload 🗙